MC
ALXN

Miles Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Miles Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,020
Closed -$218K – 190
2019
Q4 		$218K Sell
2,020
-37
-2% -$3.96K 0.17% 164
2019
Q3 		$201K Sell
2,057
-2
-0.1% -$225 0.17% 168
2019
Q2 		$270K Buy
2,059
+273
+15% +$35.2K 0.22% 116
2019
Q1 		$241K Buy
+1,786
New +$222K 0.21% 131
2018
Q4 		– Sell
-1,971
Closed -$274K – 188
2018
Q3 		$274K Buy
+1,971
New +$247K 0.22% 121

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return